AI Analysis: Key Insights from the Press Release
Show Key InsightsMarket Size (2024): US$ 6,431.04 Mn
Forecast Market Size (2031): US$ 9,722.55 Mn
CAGR (2025–2031): 6.08%
Primary Growth Drivers: Increasing Prevalence of Gastrointestinal Diseases, Growing Focus on Early Diagnosis and Screening Programs
Key Trends: Shift Towards High-Definition and 4K Imaging Systems, Rising Adoption of Disposable Flexible Endoscopes
Growth Opportunities: Development of Disposable Flexible Endoscopes, Expansion in Emerging Markets
Base Value (2024)
US$ 6,431.04 Mn
Projected (2031)
US$ 9,722.55 Mn
CAGR (2025-2031)
6.08%
As per the latest market research by Business Market Insights (BMI), the research report " Flexible Endoscopes Market Size and Forecast (2025–2031)" forecasts how the market is set to surge 51.2% by 2031. The global flexible endoscopes market is growing with advances in imaging, device flexibility, and AI-assisted visualization that improve diagnostics and treatment accuracy. Rising demand for minimally invasive and early-stage procedures drives adoption across gastroenterology, pulmonology, and urology. The shift toward single-use and portable devices further supports infection control and operational efficiency in healthcare settings worldwide.
The report forecasts the market to expand from US$ 6,431.04 million in 2024 to US$ 9,722.55 million by 2031, registering a robust CAGR of 6.08% over the 2025–2031 period.
The global flexible endoscopes market is expanding steadily as healthcare providers increasingly prefer minimally invasive procedures for diagnostics and treatment. Flexible endoscopes are commonly used in applications such as gastroenterology, pulmonology, urology, and ENT, because they can navigate complex anatomical regions without needing larger incisions. The technology, such as high-definition imaging, artificial intelligence-enabled imaging, and ergonomic improvements, addresses accuracy and efficiency in clinical practice. The advent of single-use endoscopes helps address infection control concerns and addressing the burdensome reprocessing cycles in healthcare. Rising awareness of early recognition of illness, growing healthcare spending and improved hospitals infrastructures combined has fueled growth and use of flexible endoscopy around the world. Manufacturers actively work towards creating products that are easy to use, and can be digitally connected, to meet patient needs and support the shift toward advanced, patient-centered care.
Overview of report findings
Market Growth
The flexible endoscopes market is projected to grow from US$ 6,431.04 million in 2024 to US$ 9,722.55 million by 2031, registering a compound annual growth rate (CAGR) of 6.08% between 2025 and 2031.
The flexible endoscopes market is driven by rising incidence of GI diseases, cancer, ENT diseases, urological diseases, and others. The market is also driven by rising preference of minimally invasive techniques, growing demand in outpatient setting and expansion of healthcare infrastructure.
Increasing Prevalence of Gastrointestinal Disorders
The increasing prevalence of gastrointestinal disorders such as colorectal cancer, ulcers, gastroesophageal reflux disease (GERD) and inflammatory bowel disease (IBD) is one of the key factors driving the market. This equipment assists in diagnosing and treating conditions affecting the digestive system. Lifestyle-related factors such as poor diet, high stress levels and obesity are on the rise. Due to increased awareness, healthcare providers are conducting more screenings to detect any abnormalities in various parts of the body. Flexible endoscopes are vital for diagnostics and treatment in gastroenterology, allowing routine screenings and various therapeutic procedures. Continuous improvements in endoscopic imaging quality and instrument design likewise support the expanding use of flexible endoscopy for the management of GI health problems.
Rising Preference for Minimally Invasive Procedures
The increasing interest in minimally invasive procedures among patients and healthcare professionals has been a major influence on the flexible endoscopes market. Flexible endoscopic procedures deliver smaller incisions, quicker recovery time, less pain, and decreased risk of infection when compared to open surgery. These benefits has increased the adoption of flexible endoscopes across various diagnostic and therapeutic applications in areas such as gastroenterology, urology, pulmonary medicine, and gynecology. Patients need a minimally invasive solution for both diagnostic and therapeutic procedures to reduce the amount of time in hospital and improve their post-operative outcomes. Healthcare systems also benefit from procedural cost savings and improved efficiency. The advancement of flexible endoscopes with the inclusion of high-definition images and AI innovations supports precision in the clinical setting, promotes a wider use of flexible endoscopes in practice, and facilitates wider adoption around the world.
Geographic Insights
North America is the most prominent flexible endoscopes market, underpinned by sophisticated healthcare infrastructure, maximum use of minimally invasive procedures, and availability of competent medical practitioners. Robust reimbursement policies, increasing demand for early detection and treatment of diseases, and well-established surgery programs in gastroenterology, and ENT propel the growth. The region also enjoys intense adoption of high-definition imaging, 3D visualization, and digital platforms in operating theaters. Ambulatory and outpatient operating centers more and more utilize strict endoscopes, facilitated by portable and ergonomic models.
Europe is ranked second, with high adoption of minimally invasive diagnostics and treatment in Germany, France, and the UK. Ongoing health investment, sophisticated hospital networks, and robust partnerships with device companies facilitate adoption. The region is also spurred by high R&D, advancements in sterilization technology, and patient safety focus.
The Asia Pacific market is growing at the fastest rate, driven by an increase in the incidence of cancer, and urology conditions, along with increasing healthcare infrastructure. Demand is headed by China, India, and Southeast Asia, backed by government programs, private hospital expansions, and the growing trend for cost-effective, convenient, and sophisticated flexible endoscopes.
Market Segmentation
- By product type, the flexible endoscopes market is segmented into gastrointestinal endoscopes, ENT endoscopes, uroscopes, thoracoscopes, bronchoscopes, laparoscopes, and others. The gastrointestinal endoscopes segment dominated the market in 2024.
- By usability, the flexible endoscopes market is segmented into reusable endoscopes and disposable endoscopes. The reusable endoscopes segment dominated the market in 2024.
- By application, the flexible endoscopes market is segmented into diagnostic and therapeutic. The diagnostic segment dominated the market in 2024.
- By end user, the market is segmented into hospitals, specialty clinics, ambulatory surgical centers and diagnostic centers. The hospitals segment held the largest share of the market in 2024.
Competitive Strategy & Development
Key Players: The Flexible Endoscopes market is populated by several key players, each contributing to its growth and innovation. Some prominent players are:
- Olympus Corporation
- Fujifilm Holdings Corporation
- Boston Scientific
- Karl Storz SE & Co. KG
- Stryker Corporation
- B. Braun SE
- HOYA Corporation
- Ambu
- Johnson & Johnson
- Medtronic
Trending Topics: Robotic-Assisted Endoscopy, Reusable Endoscopes, GI Endoscopy, Single-Use Flexible Endoscopes, Ultrasound Endoscope
Global Headlines
- Olympus announced FDA 510(k) clearance for EZ1500 gastroscope – On May 28, 2025, Olympus announced FDA 510(k) clearance for its most advanced imaging endoscopes, the EZ1500 gastroscope and colonoscope, featuring EDOF (Extended Depth of Field) technology. These are part of the EVIS X1 Endoscopy System, providing improved visualization and potentially aiding lesion detection in gastrointestinal procedures.
- Olympus announced FDA 510(k) clearance for RenaFlex – In April 2024, Olympus received US FDA 510(k) clearance for the RenaFlex Single-use Flexible Ureteroscope system. This is intended for diagnostic and therapeutic procedures in the urinary tract and is compatible with Olympus video system centers for single-use endoscopes.
- Zsquare received 510K clearance for ENT-Flex Rhinolaryngoscope – In July 2022, Zsquare, an Israel-based single-use endoscope manufacturer, announced that they have received Food and Drug Administration 510K clearance to market its first product, the Zsquare ENT-Flex Rhinolaryngoscope. This Rhinolaryngoscope is a flexible, single-use endoscopes indicated for use in diagnostic ENT procedures.
Conclusion
The global flexible endoscope market is set to grow rapidly. This growth stems from increasing number of people suffering from long-term illnesses like cancer, gut problems, and bladder issues. Doctors use flexible endoscopes as a main tool to look inside the body and treat it with minimal incisions. Technological innovations including high-definition and 3D imaging, AI-assisted guidance, robotic integration, and portable systems are expanding clinical applications while improving workflow efficiency and patient safety. However, there are still challenges in this market such as these devices are highly expensive, they're hard to clean, and lack of trained doctors in rural areas. Despite these challenges rising number of product launches, collaboration between manufacturer and research institutes has increased their adoption. Flexible endoscopy is increasingly recognized as essential for early diagnosis, precise interventions, and improved global healthcare outcomes
Related Press Releases
PDF
Excel
PPT